SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

ANGEL STEPHEN F

(Last)

(First)

(Middle)

C/O PRAXAIR, INC.

39 OLD RIDGEBURY ROAD

(Street)

DANBURY

06810-5113

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
PRAXAIR INC [ PX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chairman, President & CEO

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2015

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock								2,268	I	In trust for children
Common Stock								58,065	I	Grantor Retained Annuity Trusts
Common Stock								7,879.0889	I	401(k)
Common Stock	02/27/2015		M		40,786	A	$53.98	142,096.127	D
Common Stock	02/27/2015		S		40,786	D	$128.19⁽¹⁾	101,310.127	D
Common Stock	03/02/2015		M		16,242	A	$53.98	117,552.127	D
Common Stock	03/02/2015		S		16,242	D	$129.2⁽²⁾	101,310.127	D
Common Stock	03/02/2015		M		125,000	A	$61.47	226,310.127	D
Common Stock	03/02/2015		S		125,000	D	$129.38⁽³⁾	101,310.127	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy)	$53.98	02/27/2015		M			40,786	02/28/2007⁽⁴⁾	02/29/2016	Common Stock	40,786	$0	16,242	D
Stock Option (right t buy)	$53.98	03/02/2015		M			16,242	02/28/2007⁽⁴⁾	02/29/2016	Common Stock	16,242	$0	0	D
Stock Option (right to buy)	$61.47	03/02/2015		M			125,000	02/27/2008⁽⁴⁾	02/27/2017	Common Stock	125,000	$0	183,300	D
Stock Option (right to buy)	$83.89							02/26/2009⁽⁴⁾	02/26/2018	Common Stock	195,200		195,200	D
Stock Option (right to buy)	$60.92							02/24/2010⁽⁴⁾	02/24/2019	Common Stock	281,510		281,510	D
Stock Option (right to buy)	$76.16							02/23/2011⁽⁴⁾	02/23/2020	Common Stock	204,640		204,640	D
Stock Option (right to buy)	$97.84							02/22/2012⁽⁴⁾	02/22/2021	Common Stock	218,175		218,175	D
Stock Option (right to buy)	$109.68							02/28/2013⁽⁵⁾	02/28/2022	Common Stock	236,510		236,510	D
Stock Option (right to buy)	$110.58							02/26/2014⁽⁶⁾	02/26/2023	Common Stock	187,015		187,015	D
Stock Option (right to buy)	$128.8							02/25/2015⁽⁷⁾	02/25/2024	Common Stock	203,930		203,930	D
Stock Option (right to buy)	$128.38							02/24/2016⁽⁸⁾	02/24/2025	Common Stock	261,075		261,075	D
Deferred Stock Unit	$0⁽⁹⁾							⁽¹⁰⁾	⁽¹⁰⁾	Common Stock	61,187.284		61,187.284	D

Explanation of Responses:

1. The $128.19 price reported is the weighted average sale price. The sale prices ranged from $128.000 to $128.620 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.

2. The $129.20 price reported is the weighted average sale price. The sale prices ranged from $129.050 to $129.310 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.

3. The $129.38 price reported is the weighted average sale price. The sale prices ranged from $129.045 to $130.37 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.

4. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.

5. This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.

6. This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.

7. This option vests over three years in three consecutive equal annual installments beginning on February 25, 2015.

8. This option vests over three years in three consecutive equal annual installments beginning on February 24, 2016.

9. Conversion to Praxair Common Stock is on a 1-for-1 basis.

10. Deferred stock units acquired under the Praxair Compensation Deferral Program as amended and are to be settled in Praxair Common Stock.

Remarks:

	Anthony M. Pepper, Attorney-in-Fact	03/03/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.